Artemis Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-194,607	Closed	-$81.3M	–	227
2022 Q3	$81.3M	Sell	194,607 -1,180	-0.6%	-$588K	0.93%	36
2022 Q2	$97M	Buy	195,787 +96,691	+98%	+$50.4M	1%	31
2022 Q1	$55.7M	Sell	99,096 -40,881	-29%	-$24.6M	0.45%	68
2021 Q4	$106M	Buy	139,977 +13,275	+10%	+$9.93M	0.77%	36
2021 Q3	$94.4M	Buy	126,702 +13,827	+12%	+$10.4M	0.75%	35
2021 Q2	$72.8M	Buy	112,875 +29,135	+35%	+$17.7M	0.63%	47
2021 Q1	$47.8M	Sell	83,740 -25,131	-23%	-$14.9M	0.45%	63
2020 Q4	$63.6M	Sell	108,871 -24,357	-18%	-$13.9M	0.67%	46
2020 Q3	$68.6M	Sell	133,228 -65,030	-33%	-$32.9M	0.86%	30
2020 Q2	$89.7M	Sell	198,258 -60,383	-23%	-$26.6M	1.21%	20
2020 Q1	$89.9K	Buy	258,641 +146,088	+130%	+$53.7M	0.15%	14
2019 Q4	$40.7M	Buy	112,553 +20,151	+22%	+$7.1M	0.51%	61
2019 Q3	$30M	Buy	92,402 +35,638	+63%	+$11.6M	0.41%	83
2019 Q2	$17.2M	Buy	56,764 +16,936	+43%	+$5.07M	0.2%	144
2019 Q1	$12.2M	Buy	39,828 +20,477	+106%	+$5.53M	0.14%	179
2018 Q4	$4.49M	Sell	19,351 -380	-2%	-$102K	0.06%	219
2018 Q3	$6.18M	Buy	+19,731	New	+$6.12M	0.07%	236